[The treatment of essential hyperlipidemia with clofibrate].
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001797:Blood Protein Electrophoresis; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D003925:Diabetic Angiopathies / Q000188:drug therapy; D005227:Fatty Acids / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy* / Q000235:genetics; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D010743:Phospholipids / Q000097:blood; D011422:Propionates / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D005227:Fatty Acids; D005230:Fatty Acids, Nonesterified; D008055:Lipids; D008074:Lipoproteins; D010743:Phospholipids; D011422:Propionates; D002784:Cholesterol; D002994:Clofibrate
Zur Behandlung der essentiellen Hyperlipidämie mit Clofibrat.